LobbyingCalifornia Life Sciences Association lobbying by quarter
California Life Sciences Association's latest lobbying report covers Q2 2026, at $40K. The four quarters Q3 2025–Q2 2026 total $160K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Manufacturing.
California Life Sciences Association
- Latest quarter
- $40K
- Q2 2026 · 1 reports
- Last 12 months
- $160K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $40K | 1 |
| Q1 2023 | $40K | 1 |
| Q2 2023 | $40K | 1 |
| Q3 2023 | $40K | 1 |
| Q4 2023 | $40K | 1 |
| Q1 2024 | $40K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
Policy issues the reports name
- Health issues15 reports
- Manufacturing15 reports
- Medical research and clinical labs15 reports
- Medicare and Medicaid15 reports
- Pharmacy15 reports
- Taxation15 reports
- Trade15 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $600K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MICHAEL ALEXANDER WILLIAMS | Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Forbes-Tate | $40K |
| 04/17for Q1 | Forbes-Tate | $40K |
| 01/18for Q4 2025 | Forbes-Tate | $40K |
| 25/10/19for Q3 2025 | Forbes-Tate | $40K |
| 25/07/18for Q2 2025 | Forbes-Tate | $40K |
| 25/04/17for Q1 2025 | Forbes-Tate | $40K |
| 25/01/17for Q4 2024 | Forbes-Tate | $40K |
| 24/10/17for Q3 2024 | Forbes-Tate | $40K |
| 24/07/14for Q2 2024 | Forbes-Tate | $40K |
| 24/04/12for Q1 2024 | Forbes-Tate | $40K |
| 24/01/16for Q4 2023 | Forbes-Tate | $40K |
| 23/10/18for Q3 2023 | Forbes-Tate | $40K |
| 23/07/16for Q2 2023 | Forbes-Tate | $40K |
| 23/04/17for Q1 2023 | Forbes-Tate | $40K |
| 23/01/15for Q4 2022 | Forbes-Tate | $40K |